Editor's key points † The use of selective decontamination of the digestive tract (SDD) in the UK remains low. † This survey compared outcomes and infection rates from 205 UK critical care units. † There were no significant differences in risk-adjusted outcomes between the 9 units using SDD and the 196 units not using SDD. † Subgroup analysis suggests that there were fewer unit-acquired blood stream infections when an i.v. SDD component was used. † However, this is based on data from three units.
† However, this is based on data from three units.
Background. Evidence supporting selective decontamination of the digestive tract (SDD) is reasonably strong. We set out to determine use in UK critical care units and to compare patient outcomes between units that do and those that do not use SDD.
Methods. A total of 250 UK general critical care units were surveyed. Case mix, outcomes, and lengths of stay for admissions to SDD units (with and without an i.v. component) and non-SDD units were compared using data from the Intensive Care National Audit & Research Centre Case Mix Programme database.
Results. A response was received from all the 250 critical care units surveyed. Of these, 13 (5.2%) reported using SDD on some or all admissions, and of these, 3 reported using an i.v. component. Data on 284 690 admissions (April 2008 -March 2011) from units reporting to the ICNARC Case Mix Programme (CMP) were included in the analyses. Admissions to SDD (n¼196) and non-SDD (n¼9) units were a similar case mix with similar infection rates and average lengths of stay in the unit and hospital. There was no difference in risk-adjusted unit or hospital mortality. The rate of unit-acquired infections in blood was significantly lower in SDD units using an i.v. component.
Conclusions.
Use of SDD in UK critical care is very low. The rate of unit-acquired infections in blood was significantly lower in SDD units using an i.v. component, but did not translate into a difference in acute hospital mortality or length of stay. There is a need to better understand the barriers to adoption of SDD into clinical practice and such work is underway.
Keywords: antibacterial agents; critical care; epidemiology; infection Accepted for publication: 21 January 2014 Critically ill patients are extremely susceptible to hospitalacquired infections (HAIs) which are associated with an excess mortality, prolonged hospital stays, and a high healthcare resource utilization. It is estimated that 30% of patients in critical care units are affected by HAIs. Risk factors include use of invasive devices, such as vascular catheters and invasive mechanical ventilation. In addition, certain conditions predispose patients to bacterial colonization, thereby increasing the risk of HAIs. A number of strategies for preventing HAIs have been suggested, including selective decontamination of the digestive tract (SDD), which involves the application of topical nonabsorbable antibiotics to the oropharynx and stomach and a short course of i.v. antibiotics. 2 -12 The principle of this treatment is to prevent HAIs by selectively killing the patient's endogenous aerobic Gram-negative bacilli to prevent overgrowth of these organisms, which are known to cause HAIs, such as ventilator-associated pneumonia. The evidence supporting SDD is reasonably strong. 13 A reported that SDD reduced 28-day mortality by an estimated 3.5% compared with standard care. 14 Despite the evidence, previous surveys have indicated poor uptake of SDD in critical care units. 15 16 We set out to determine the current use and de- Units reporting adoption of SDD were followed up and asked to complete a short questionnaire, via telephone, about SDD delivery including: the content of SDD and route of delivery; the types of patients receiving SDD; the point at which SDD is commenced and duration of treatment; and the date the unit commenced using SDD (Supplementary Appendix S1). Telephone interviews were conducted with senior nurses or medical consultants. All data collection was completed by August 2011.
The analysis comparing patient outcomes between units that reported using SDD (SDD units) and those that reported not using SDD (non-SDD units) was based on data from the ICNARC Case Mix Programme (CMP) database. The CMP is the national comparative clinical audit for adult critical care units (including ICUs and combined ICU/HDUs) in England, Wales, and Northern Ireland, coordinated by ICNARC. Participation in the CMP is voluntary, and currently 94% of all possible adult, general, critical care units in England, Wales, and Northern Ireland participate in the CMP. The CMP includes the mandated fields for the Department of Health's Critical Care Minimum Dataset for Payment by Results. It is listed as a recognized national clinical audit for inclusion in the Department of Health's Quality Accounts for 2013/14. Trained data collectors collect raw data to precise rules and definitions, which then undergo extensive local and central validation before pooling. The CMP database thus contains pooled case mix and outcome data collected on consecutive admissions to units participating in the CMP and has been independently assessed to be of high quality. 17 Data were extracted from the CMP database for all admissions to SDD and non-SDD units participating in the CMP between April 2008 and March 2011. Admissions to SDD units were compared with admissions to non-SDD units with regard to case mix, outcomes, and lengths of stay, taking account of the date that SDD was adopted in the unit. Case mix was described by: age; sex; surgical status, based on admission to the unit direct from the operating theatre and categorized by urgency of surgery according to the definitions of the National Confidential Enquiry into Patient Outcome and Death; and acute severity of illness, assessed by the Acute Physiology And Chronic Health Evaluation (APACHE) II Acute Physiology Score, APACHE II Score, and the ICNARC Physiology Score. 18 19 Outcomes, routinely reported as part of the CMP,
were: unit-acquired infection rates (identified from clinical microbiological samples taken more than 48 h after admission to the unit); unit-acquired methicillin-resistant Staphylococcus aureus (MRSA); unit-acquired vancomycin-resistant enterococcus (VRE); critical care mortality; and hospital mortality. Unit-acquired infections reported were: any unit-acquired infection in blood (identified from a blood sample, excluding contaminants, taken through skin venepuncture), and infections because of Clostridium difficile (defined as the detection of C. difficile toxin in any stool sample taken for microbiological examination 48 h after admission to the unit and while still in the unit). Unit-acquired MRSA and VRE were defined as the presence of MRSA or VRE in any sample taken for microbiological examination 48 h after admission to the unit and while still in the unit. Mortality was assessed at discharge from the original critical care unit and at discharge from acute hospital. Length of stay was reported in the original critical care unit and the total stay in acute hospital, stratified by survival status.
Outcomes were compared between SDD units and non-SDD units using multilevel, random-effects logistic regression models, adjusted for secular trend (linear effect of calendar time), predicted log odds of acute hospital mortality from the ICNARC risk prediction model (2011 recalibration) and random effect of unit. 19 As a sensitivity analysis, the analyses were repeated comparing units that reported delivering SDD that included an i.v. component with non-SDD units. Units that reported using SDD comprising oropharyngeal nasogastric paste, or both only were excluded from this analysis.
As a subgroup analysis, the analyses were repeated among admissions with a primary or secondary reason for admission to the critical care unit of trauma (identified from the process tier of the hierarchical ICNARC Coding Method). 20 Units that reported using SDD in all admissions or specifically in trauma admissions were compared with non-SDD units. Units that reported using SDD in specific patient groups other than trauma were excluded from this analysis. Approval from a Research Ethics Committee was not required as the study did not involve recruiting patients or healthcare staff as research participants. Support for the collection and use of patient-identifiable data without consent for the CMP has been obtained under Section 251 of the NHS Act 2006 (approval number PIAG 2-10(f)/2005).
Results
A response to the email questionnaire was received from all the 250 (100%) adult, general critical care units contacted. Of the 250 respondents, 13 (5.2%) reported using SDD in Observational study of current use of selective decontamination some or all admissions. The type and delivery of SDD as reported by the 13 units are provided in Table 1 . Over half of the units (n¼7) reported using SDD in ventilated patients. Three units reported using SDD in trauma patients only and one unit in patients with liver or liver-related problems only. Three out of the 13 units included an i.v. component in addition to oral, nasogastric paste, or both. The composition varied across units. Typically, units reported that SDD is commenced either on admission to the unit (n¼11) or after intubation/ tracheostomy (n¼3), and continued until either weaning from mechanical ventilation (n¼3) or extubation (n¼7). Five units reported having used SDD for ≥10 yr and two units have introduced SDD in the last 3 yr. Of the 13 units that reported using SDD, 9 actively participate in the CMP, including the 3 units that reported including an i. Table 2 .
Admissions to SDD units (n¼9) were of an age and a severity of illness similar to those of admissions to non-SDD units (n¼196). However, the percentage of patients having elective or scheduled surgery was higher in SDD units than in non-SDD units (29.3 vs 21.8%). The rates of the unit-acquired infections MRSA and VRE were similar between SDD and non-SDD units. Crude mortality at discharge from the critical care unit and at discharge from acute hospital was slightly lower in SDD units (15.4 vs 16.7% and 22.7 vs 24.9%, respectively). The average length of stay in the critical care unit and in acute hospital was similar between the two groups for all-comers, survivors, and non-survivors.
Comparisons of SDD units that include an i.v. component (n¼3) with non-SDD units were difficult, given the small number of units. However, despite the small sample size, it is interesting to note that the rate of unit-acquired infections in blood was lower (0.1%) in these units compared with the rate (2.8%) in non-SDD units.
Seven units reported using SDD in trauma patients. Trauma admissions to these units were similar with regard to age and severity of illness to trauma admissions to non-SDD units. However, a lower proportion of patients were admitted to SDD units after emergency or urgent surgery compared with non-SDD units (36.5 vs 44.2%). The rates of unit-acquired infections MRSA and VRE and critical care unit and acute hospital mortality were similar in the two groups. There were also no differences in critical care unit and acute hospital length of stay. Figure 1 summarizes the results of the multilevel logistic regression models. After adjustment for secular trends, severity Observational study of current use of selective decontamination BJA of illness, and unit-level random effects, there were no statistically significant differences in outcomes between admissions to SDD and non-SDD units, except for a significant lower rate of unit-acquired infections in blood in admissions to SDD units that used an i.v. component (odds ratio 0.09, 95% confidence interval 0.01-0.63, P¼0.015).
Discussion
This study sought to explore the current use and delivery of SDD in NHS adult, general critical care units in the UK and to compare patient outcomes between units that use SDD and units that do not. It uniquely benefitted from a 100% response rate to the survey of critical care units and the availability of nationally representative, comprehensive, and prospectively collected data on patient outcomes.
The survey component of this study has demonstrated that use of SDD in UK NHS adult, general critical care units is very low. Of the units that reported using SDD, most were delivering topical antibiotics only, with ,1% including an i.v. component. We found very few differences between SDD and non-SDD units with regard to case mix and patient outcomes. Despite the rate of unit-acquired infections in blood being significantly lower in SDD units that included an i.v. component, this reduction in infections did not translate into a difference in acute hospital mortality or length of stay.
Our results are consistent with the two previous surveys.
15 16 Shah and colleagues 15 reported a response from 249 out of 256
English ICUs surveyed, of which 6% reported using SDD. No information was provided on the types of ICUs included in the sampling frame or when the survey was conducted. Bastin and Ryanna 16 surveyed 272 UK NHS ICUs (including specialist
ICUs, e.g. cardiothoracic and liver) listed in the Directory of Critical Care 2006 (CMA Medical Data, Loughborough, UK). They achieved a 71% response rate with 5% of respondents reporting using SDD. Strengths of this study include achieving a 100% response rate, which is unusual in surveys of clinical practice. We also linked the survey data to data from a high-quality clinical database to enable a comparative analysis of case mix and patient outcomes. This allowed analysis of outcomes of a large number of non-SDD patients in our study and we believe that these patients are representative of UK practice. However, the small number of SDD units means that the results must be interpreted with caution. There were some differences in case mix between the SDD and non-SDD units which we attempted to control for in our multilevel, random-effects logistic regression models. However, such comparisons are at risk of bias because of the potential for residual confounding with unmeasured covariates and are thus imperfect. It is unclear what effect residual confounding and imperfect adjustment could have on these results. Since the SDD units have more elective surgical patients and slightly lower severity of illness scores, this could lead to a bias towards the null when SDD units actually had a higher risk-adjusted mortality. Despite presenting evidence on unit-acquired MRSA and VRE rates, we did not have access to more detailed data on antibiotic resistance and how it changed over time in SDD vs non-SDD units. In addition, we may have underestimated the true rates of unit-acquired infections MRSA and VRE as we did not have information from microbiological samples taken during the 48 h after critical care discharge. These data are important for clinical practice to understand the place of SDD in practice.
In summary, our results are suggestive of cautious support for the benefits of SDD in potentially reducing bacteraemia (when the i.v. component is adopted). The impact of SDD on other outcomes was less apparent, with no demonstrable benefit observed on mortality. However, this was a non-randomized comparison of SDD and non-SDD units, and although the analysis was risk-adjusted, the possibility of residual confounding cannot be excluded. Despite the results of a recent large cluster randomized controlled trial suggesting that SDD improves outcomes, our survey indicates that uptake in the UK remains low. 14 We did not ask non-SDD units reasons for not using SDD; however, concerns about driving antibiotic resistance with SDD have previously been identified and cited as a key reason for the limited adoption of SDD. 16 22 Although we found similar rates of unit-acquired MRSA and VRE in SDD and non-SDD units, we were limited in our ability to further study effects of SDD on antibiotic resistance patterns. A recent report suggested that SDD is associated with lower rates of bacteraemia and respiratory tract colonization with highly resistant microorganisms. 21 Clearly, there is a need to understand better the barriers to adoption of SDD into clinical practice and such work is underway. 13 
